NORGES BANK - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORGES BANK ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$697,500
-71.8%
279,000
-68.5%
0.00%
-100.0%
Q2 2022$2,475,070
-47.4%
887,122
+7.7%
0.00%0.0%
Q1 2022$4,709,402
-36.2%
823,322
+1.8%
0.00%
-50.0%
Q4 2021$7,386,000
-14.6%
808,960
+0.0%
0.00%0.0%
Q3 2021$8,647,000
-7.1%
808,865
+34.8%
0.00%0.0%
Q2 2021$9,310,000
-4.1%
599,865
+0.1%
0.00%0.0%
Q1 2021$9,712,000
-60.7%
599,119
-48.6%
0.00%
-66.7%
Q4 2020$24,691,000
+20.7%
1,166,605
-15.5%
0.01%
+20.0%
Q3 2020$20,456,000
-6.3%
1,380,271
-7.0%
0.01%
-16.7%
Q2 2020$21,836,000
+64.6%
1,484,415
+31.4%
0.01%
+20.0%
Q1 2020$13,266,000
-43.3%
1,129,998
+13.6%
0.01%
-28.6%
Q4 2019$23,384,000
+57.6%
995,080
+24.1%
0.01%
+40.0%
Q3 2019$14,833,000
+10.0%
801,791
+10.5%
0.01%
+25.0%
Q2 2019$13,488,000
-14.7%
725,523
+12.1%
0.00%
-20.0%
Q1 2019$15,816,000
+15.6%
647,140
+22.7%
0.01%0.0%
Q4 2018$13,679,000
-5.3%
527,351
+15.5%
0.01%0.0%
Q3 2018$14,446,000
+643.5%
456,439
+812.9%
0.01%
+400.0%
Q2 2018$1,943,000
+501.5%
50,000
+150.0%
0.00%
Q3 2017$323,000
+16.6%
20,0000.0%0.00%
Q2 2017$277,000
-7.7%
20,0000.0%0.00%
Q1 2017$300,00020,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders